PMID int64 27.8M 36.2M | Title/Abstract stringlengths 7 10.7k | MeshTerms stringlengths 7 104 | SemanticTypes stringlengths 4 84 |
|---|---|---|---|
34,664,435 | enhanc knowledg mental health issu among children nurs student evalu servic user led workshop past year number children young peopl mental health issu increas clinic placement children nurs student often encount servic user well mother mental health issu postnat depress mani student report feel inadequ prepar meet need servic user | D004508;D013338 | T097;T065 |
34,664,434 | role nurs patient blood manag treat anaemia patient blood manag defin patient focus evid base approach optimis manag patient transfus blood compon articl explor complex factor influenc clinic decis enhanc patient safeti administr blood compon particular red blood cell transfus patient anaemia articl also explor nurs role act patient advoc consid altern use blood compon articl focus anaemia relat transfus author relat principl patient blood manag transfus care | D000740;D024802 | T047;T054 |
34,664,432 | opioid antagonist naltrexon decreas seizur like activ genet chemic induc epilepsi model signific number epilept patient fail respond avail anticonvuls medic find new anticonvuls medic evalu fda approv drug known anticonvuls use zebrafish larva initi model system found opioid antagonist naltrexon exhibit anticonvuls effect valid effect three epilepsi model present naltrexon promis anticonvuls candid | D004827;D009271 | T033;T047;T121;T109 |
34,664,431 | comput tomographi defin low skelet muscl index densiti cancer patient observ systemat review comput tomographi ct analysi bodi composit garner interest potenti prognost tool cancer rang pre defin threshold current exist within literatur defin low skelet muscl mass densiti aim present systemat review assess preval low skelet muscl index smi densiti smd within literatur across rang common solid tumour | D008175;D018482 | T191;T023;T024 |
34,664,429 | impact oncotyp dx test adjuv chemotherapi decis make node posit breast cancer oncotyp dx test reduc use adjuv chemotherapi node negat earli breast cancer less known impact node posit patient | D001943 | T191 |
34,664,428 | delay diagnosi treatment breast cancer vietnam delay diagnosi treatment first notic breast cancer symptom associ poor outcom understand reason barrier patient delay seek medic care critic mitig problem | D007722;D010342;D061665 | T079;T055;T033;T053;T058;T080 |
34,664,427 | safeti toler pharmacokinet mevidalen ly central act dopamin receptor posit alloster modul patient parkinson diseas mevidalen ly posit alloster modul dopamin receptor enhanc affin dopamin receptor safeti toler motor effect pharmacokinet mevidalen studi patient parkinson diseas mevidalen placebo given daili day cohort patient cohort mg cohort titrat mg cohort median time maximum concentr mevidalen plasma concentr hour appar steadi state clearanc lh mevidalen plasma concentr similar st th administr cohort indic minim accumul upon repeat dose mevidalen well toler treatment emerg advers event mild blood pressur puls rate increas take mevidalen consider overlap patient take placebo vital sign normal repeat dose movement disord societi unit parkinson diseas rate scale patient take mevidalen show better motor examin sub score day compar patient placebo group data support examin mevidalen symptomat treatment patient parkinson diseas lewi bodi dementia | D018696;D010300 | T047;T169;T121 |
34,664,426 | prognost impact systol blood pressur acut heart failur preserv eject fraction older patient recent guidelin recommend systol blood pressur sbp target mmhg heart failur patient preserv eject fraction hfpef whatev age investig whether intens sbp control associ better surviv old adult hospit acut hfpef | D006333 | T047;T046 |
34,664,421 | comparison effect qmix convent root canal irrig push bond strength fiber post root dentin studi aim assess effect applic qmix common root canal irrig solut bond strength fiber post root dentin | D001840;D012388 | T122;T061 |
34,664,420 | microfractur acetabular rim segment labral resect restor morpholog function labrum retrospect studi year follow report clinic outcom patient undergo combin arthroscop treatment labral resect microfractur rim acetabulum minimum year follow | D015775 | T046;T037 |
34,664,419 | portal setup key point learn curv hip arthroscopi techniqu analyz learn curv experi hip arthroscopi base patient demograph surgic time portal setup time postop complic find key point learn curv | D002983;D059032 | T080;T041 |
34,664,410 | acut toxic patient report symptom score convent versus moder hypofraction proton therapi prostat cancer confirm feasibl hypofraction proton beam therapi pbt compar acut advers event rate intern prostat symptom score ipss prostat cancer patient treat hypofraction versus convent fraction gy relat biolog effect rbe fraction pbt | D011471;D061766 | T191;T061 |
34,664,409 | antithrombot anticoagul therapi cardiogen shock critic review publish literatur cardiogen shock cs complex multifactori clinic syndrom develop continuum progress initi insult under caus subsequ occurr organ failur death larg phenotyp variabl cs result divers aetiolog pathogenet mechan haemodynam stage sever although earli revascular remain import intervent cs set acut myocardi infarct administr time effect antithrombot therapi critic improv outcom patient addit clinic set non acut myocardi infarct aetiolog associ high thrombot risk may requir specif regimen short term long term antithrombot therapi cs alter tissu perfus inflamm multi organ dysfunct induc unpredict alter antithrombot drug pharmacokinet pharmacodynam intervent use manag cs mechan circulatori support renal replac therapi target temperatur manag influenc thrombot bleed risk may requir specif antithrombot strategi order optim safeti efficaci therapi cs antithrombot manag adapt cs clinic scenario specif devic individu antithrombot regimen term type treatment dose durat addit patient cs requir close appropri monitor antithrombot therapi safe balanc increas risk bleed thrombosi | D009203;D012770 | T047;T046 |
34,664,408 | yaptaz atf drive resist sorafenib hepatocellular carcinoma prevent ferroptosi understand mechan under evas resist cancer unmet medic need improv efficaci current therapi studi combin shrna mediat synthet lethal screen transcriptom analysi reveal transcript factor yaptaz key driver sorafenib resist hepatocellular carcinoma hcc repress sorafenib induc ferroptosi mechanist tead depend manner yaptaz induc express slca key transport maintain intracellular glutathion homeostasi thus enabl hcc cell overcom sorafenib induc ferroptosi time yaptaz sustain protein stabil nuclear local transcript activ atf turn cooper induc slca express studi uncov critic role yaptaz repress ferroptosi thus establish sorafenib resist hcc highlight yaptaz base rewir strategi potenti approach overcom hcc therapi resist | D006528;D000079403;D008113 | T043;T191 |
34,664,407 | arni versus aceiarb reduc cardiovascular outcom myocardi infarct studi aim compar efficaci angiotensin receptor neprilysin inhibitor arni therapi angiotensin convert enzym inhibitor angiotensin receptor blocker aceiarb therapi cardiovascular outcom patient acut myocardi infarct ami | D057911;D000806;D009203 | T047;T121 |
34,664,403 | loss redd prevent chemotherapi induc muscl atrophi weak mice chemotherapi essenti treatment combat solid tumour mitig metastasi chemotherapi caus side effect includ muscl wast weak regul develop dna damag respons redd stress respons protein repress mechanist target rapamycin mtor complex mtorc express increas model muscl wast aim studi determin delet redd suffici attenu chemotherapi induc muscl wast weak mice | D000970;D014157 | T116;T121;T109;T123 |
34,664,402 | import rna modif cell muscl physiolog natur occur post transcript chemic modif serv critic role impact rna structur function direct modif may affect rna stabil intracellular transport translat effici fidel combin effect caus modif ultim link gene express regul genom wide scale latter especi true system undergo rapid metabol translat remodel respons extern stimuli presenc stressor beyond modif may also affect cell homeostasi although exampl import rna modif translat accumul rapid still contribut function complex physiolog system muscl recent emerg present review introduc key inform various modif highlight connect cellular malfunct pass describ well document role modif nervous system use inform step stone emphas glare pauciti knowledg role rna modif heart skelet muscl particular emphasi mitochondri function system articl categor rna diseas develop rna diseas rna process rna edit modif | D012313;D012323 | T114;T045 |
34,664,401 | inter intra individu concentr direct oral anticoagul kidoac studi direct oral anticoagul doac requir concentr monitor howev whether doac concentr stabl variat within patient well studi | D000925;D000069604 | T121;T109 |
34,664,400 | integr comput immunogenom profil cortisol secret adrenocort carcinoma adrenocort carcinoma acc rare high aggress malign near half acc tumour overproduc secret adren steroid excess cortisol secret particular associ poor prognosi among acc patient furthermor recent immunotherapi clinic trial demonstr signific immunoresist among cortisol secret acc cs acc patient compar non cortisol secret nonc acc counterpart immunosuppress role excess glucocorticoid therapi hypersecret known howev impact cortisol hypersecret acc tumour microenviron tme immun express profil immun cell respons remain larg undefin studi character tme acc patient compar immunogenom profil nonc acc cs acc tumour assess impact differenti express gene deg util cancer genom atlas tcga databas immunogenom comparison cs vs nonc acc tumour tmes demonstr immunosuppress express profil direct impact patient surviv identifi sever primari prognost indic potenti target within acc tumour immun landscap differenti express immun gene prognost signific provid addit insight understand potenti contributori mechan under failur initi immunotherapeut trial poor prognosi patient cs acc | D019295 | T091 |
34,664,399 | xanthorrhizol inhibit non small cell carcinoma cell growth promot apoptosi modul pikakt nf b signal pathway xanthorrhizol xnt sesquiterpenoid agent isol curcuma xanthorrhiza known exhibit various pharmacolog activ includ anti cancer investig anti cell prolif proapoptot effect xnt non small cell carcinoma cell analyz generat reactiv oxygen speci ros alter mitochondri membran potenti oxid dna damag apoptosi morpholog chang explor hoechst aoetbr stain studi demonstr xnt treatment signific reduc viabil cell concentr depend manner observ xnt induc oxid stress mediat apoptot cell death increas intracellular ros generat deplet antioxid level enhanc lipid peroxid increas apoptot morpholog chang dna damag human lung cancer cell furthermor observ xnt induc apoptosi inhibit phosphoryl pik aktand inhibit nf bp transcript signal activ addit xnt treatment alter therebi induc apoptosi close coordin induct pro apoptot marker bax bad caspas cytochrom c suppress anti apoptot bcl bcl xl protein express accord result xnt induc apoptosi cell caus oxid damag modul apoptot signal event final xnt induc apoptot cell death confirm tunel assay therefor xnt might use chemotherapeut agent treatment lung cancer | D019869;D051057 | T116;T126 |
34,664,398 | microbi divers associ metabol potenti supraglaci habitat fast retreat glacier case studi patsio glacier north western himalaya present studi investig microbi communiti composit associ metabol potenti use rrna gene v v amplicon sequenc approach patsio glacier bacteri communiti composit main domin bacteroidota total read cyanobacteria along rare candid phylum patescibacteria ferruginibact polaromona domin genera identifi across sampl known potenti ecolog role colon drive function supraglaci habitat preval metabol gene associ nitrogen carbon sulfur cycl process identifi present studi fungal divers domin member unclassifi phyla follow ascomycota basidiomycota term relat abund relat abund fusarium didymella higher among high altitud cryoconit sampl p p rhodotorula domin glacial ice debri sampl p p thus studi provid signific insight dynam microbi communiti potenti ecolog role chang climat | D000458;D064307 | T001;T032;T007;T028 |
34,664,397 | comprehens phenotyp human peripher blood b lymphocyt healthi condit b cell compart provid innat adapt immun defens pathogen differ b cell subset reflect matur stage b cell noninterchang function role innat adapt immun respons review provid overview b cell subset present peripher blood healthi individu specif gate strategi also describ clear univoc identifi b cell subset base phenotyp trait flow cytometr analysi | D001402 | T025 |
34,664,396 | pattern determin dispers grey wolv cani lupus dispers key demograph process involv three stage emigr transienc settlement influenc individu social environment determin integr understand speci dispers essenti demograph model conserv plan review dispers pattern determin document scientif literatur grey wolf cani lupus across distribut rang show surpris high variabl within among studi area dispers paramet dispers rate direct distanc durat success found larg variabl due multipl individu social environment determin also due previous overlook methodolog research issu reveal potenti non linear relationship dispers rate popul densiti dispers rate higher end gradient popul densiti found human caus mortal reduc distanc durat success dispers event furthermor dispers avoid interact human high expos area like agricultur land hamper popul connect mani case identifi numer methodolog research problem make difficult obtain robust estim dispers paramet robust infer dispers pattern determin particular analys confound factor account led substanti knowledg gap aspect dispers otherwis much studi speci understand wolf biolog manag would signific benefit wolf dispers studi report result possibl factor affect wolf dispers transpar | D019596 | T015 |
34,664,394 | circul tumor cell base messeng rna score system prognost hepatocellular carcinoma translat tissu base messeng rna profil noninvas set numer studi hepatocellular carcinoma hcc propos tissu base gene signatur individu prognost assess develop novel circul tumor cell ctc base transcriptom profil assay translat tissu base messeng rna mrna signatur liquid biopsi set noninvas hcc prognost hcc ctc mrna score system combin nanovelcro ctc assay enrich hcc ctcs nanostr ncounter platform quantifi hcc ctc risk score rs panel enrich hcc ctcs prognost role hcc ctc rs assess cancer genom atlas tcga hcc cohort n valid independ clinic ctc cohort n hcc ctc rs panel develop integr data analysi framework hcc tissu base gene signatur identifi top prognost gene discoidin domain receptor tyrosin kinas ddr enoyl coa hydratas hydroxyacyl coa dehydrogenas ehhadh androgen receptor ar lumican lum hydroxysteroid beta dehydrogenas hsdb prostat transmembran protein androgen induc pmepa tsukushi small leucin rich proteoglycan tsku n termin ef hand calcium bind protein necab ladinin lad solut carrier famili member slca high express hcc low express white blood cell panel accur discrimin overal surviv tcga hcc cohort hazard ratio hr confid interv ci combin use score system hcc ctc rs panel success distinguish artifici blood sampl spike aggress hcc cell type snu spike plcprf cell p ctc valid cohort n hcc ctc rs remain independ predictor surviv hr ci p control model end stage liver diseas score barcelona clinic liver cancer stage ctc enumer count studi demonstr novel interdisciplinari approach translat tissu base gene signatur liquid biopsi set noninvas approach allow real time diseas profil dynam prognost hcc | D006528;D058625;D008113;D016031;D009360 | T025;T191;T047;T061 |
34,664,393 | predict total corneal power measur anterior corneal power iolmast use feedforward shallow neural network corneal back surfac known add astigmat rule consid cataract surgeri toric len implant purpos studi set deep learn algorithm predict total corneal power keratometri biometr measur | D001251;D007910;D018918 | T074;T047;T061 |
34,664,391 | magnitud progress lean bodi mass fat free mass skelet muscl mass loss follow bariatr surgeri systemat review meta analysi postbariatr loss muscl tissu could negat affect long term health due role various bodili process metabol function capac meta analysi aim unravel time depend chang magnitud progress lean bodi mass lbm fat free mass ffm skelet muscl mass smm loss follow bariatr surgeri systemat literatur search conduct pubm embas web scienc fifti nine studi assess lbm n ffm n smm n preoper time point postsurgeri random effect meta analys perform determin pool loss per outcom paramet follow time point month postsurgeri pool lbm loss kg ci ffm loss smm loss kg ci kg ci respect month lbm loss occur within month postsurgeri follow gradual decreas month similar pattern seen ffm smm conclus kg lbm ffm loss observ within year postsurgeri lbm ffm smm predomin lost within month postsurgeri highlight intervent mitig loss implement periop | D050110 | T061 |
34,664,389 | covid diseas map comput knowledg repositori virus host interact mechan need effect combin knowledg surg literatur complex dataset propos mechanist model sar cov infect improv data interpret predict key target intervent describ larg scale communiti effort build open access interoper comput repositori covid molecular mechan covid diseas map cdmap graphic interact represent diseas relev molecular mechan link mani knowledg sourc notabl comput resourc graph base analys diseas model end establish framework tool platform guidelin necessari multifacet communiti biocur domain expert bioinformatician comput biologist diagram cdmap curat literatur integr relev interact text mine databas demonstr applic network analysi model approach concret exampl highlight new testabl hypothes framework help find signatur sar cov predisposit treatment respons prioritis drug candid approach may help deal new wave covid similar pandem long term perspect | D016208;D012984 | T170;T073;T090 |
34,664,388 | resveratrol improv follicular develop pcos rat regul glycolyt pathway polycyst ovari syndrom pcos common endocrin metabol disord caus infertil howev under mechan remain ill defin avail drug strategi treatment pcos studi examin therapeut effect resveratrol rat model pcos | D011085 | T047 |
34,664,387 | signific probiot remodel gut consortium enhanc immun caenorhabd elegan recent past caenorhabd elegan emerg one lead nematod model studi host microb interact molecular cellular organism level general morpholog function similar gut c elegan respect human brought specul studi intestin microbiota hand probiot prove efficaci metabol develop pathogenesi therebi induc immun respons c elegan nurtur c elegan probiot led immunomodulatori effect intestin microbiota propos c elegan one vivo screen criteria select potenti probiot bacteria host health promot factor major prospect probiot exert longev toward host divers environment condit extent research probiot metabol shed light mechan immunomodulatori effect exert nematod model review discuss various aspect effect probiot improv health mechan involv confer immun c elegan | D019936 | T007 |
34,664,386 | time resolv dosimetri pencil beam scan qualiti assurancequ control particl therapi studi aim measur dose scan carbon beam irradi field high sampl rate suffici identifi spot verifi characterist scan beam general deriv dose identifi spot smallest control unit beam inform irradi effect measur sampl time shorter necessari provid dose within specif time refer time resolv dose trd design circuit time resolv dosimetri use fast data acquisit unit sl yokogawa electr co measur sampl per second moreov use convert enabl connect ionize chamber ic sl trd measur success use point irradi two dimension irradi pattern scan carbon beam base move time spot obtain posit monitor dose deliv ic spot posit spot dose interpret spot dose displac chamber beam center axi beam size deriv use trd posit monitor output measur concurr trd spot dose radius mm area ic center observ use spot dose equat simul show spot dose posit vari depend beam size displac ic center beam center axi devis interpret method characterist may appli qualiti assur verif trend beam axi isocent coincid well beam size verif | D061766 | T061 |
34,664,385 | treatment microvascular invas hepatocellular carcinoma drug load nanocomposit platform synergist effect magnet fieldnear infrar light despit progress clinic treatment microvascular invas mvi remain major factor frequent recurr metastasi hepatocellular carcinoma hcc liver resect surgeri thus studi construct target nanoplatform cd uspio au ddp magnet fieldnear infrar nir light respons use ultrasmal superparamagnet iron oxid gold nanopor sphere uspio au multifunct nanocarri anticanc drug cisplatin ddp load specif express cd protein mvi taken therapeut target cd uspio au ddp show favor phototherm stabl properti nir light nm wavelength suggest vitro vivo research composit nanoprepar could effect reduc damag normal organ show good biocompat excel magnet target function nanocarri modif cd strengthen accumul composit nanodrug tumor inhibit tumor growth system may import ramif treatment mvi hcc | D006528;D008113;D053761 | T191;T073 |
34,664,384 | technolog resourc teach learn human anatomi medic cours systemat review literatur consolid technolog altern strategi cadaver dissect teach anatomi medic cours acceler recent covid pandem caus need social distanc polici closur laboratori classroom consequ new technolog creat alreadi develop start better explor howev inform mani instrument resourc avail anatomi teacher systemat review present technolog mean teach learn human anatomi develop appli medic cours last ten year besid infrastructur necessari use studi english portugues spanish search medlin scopus eric lilac scielo databas initi result total identifi articl includ analysi classifi accord type technolog use three dimension print n extend realiti n digit tool n technolog resourc n made detail descript technolog includ stage medic curriculum appli infrastructur util content cover analysi show technolog relat internet print applic student learn financi cost necessari structur implement | D000715;D000086382;D013337 | T091;T047;T097;T067 |
34,664,383 | paediatr appendic neuroendocrin tumour review case singl center appendic neurendocrin tumour net rare neoplasm diagnosi common incident follow appendectomi aim review experi appendic net | D001063;D001064;D001065;D002276;D018358 | T191;T047;T023 |
34,664,382 | thiosulf oxid sulfur reduc shewanella oneidensi unexpect influenc cytochrom c content thiosulf import form sulfur compound serv electron donor acceptor various microorgan shewanella oneidensi bacterium renown respiratori versatil thiosulf reduct long recogn whether catalys thiosulf oxid remain elus studi discov oneidensi capabl thiosulf oxid process specif catalys two periplasm cytochrom c cyt c protein tsda tsdb act catalyt subunit electron transfer subunit respect presenc oxygen oxid thiosulf prioriti reduct intrigu thiosulf oxid negat regul cyt c content oneidensi cell larg reduc intracellular level camp cofactor modul activ global regul crp requir transcript mani cyt c gene unexpect find provid addit dimens interplay respir regul respiratori pathway oneidensi moreov data present identifi oneidensi first bacterium known date own function thiosulf reductas dehydrogenas import genom analys suggest number bacteri speci possess featur rather limit | D020592;D013885 | T007;T197 |
34,664,381 | cannabinoid interact transient receptor potenti famili implic treatment rosacea recent interest medic marijuana research cannabinoid regain wider attent cannabinoid collect group activ compound produc anim endocannabinoid plant phytocannabinoid synthet act number differ receptor like cannabinoid receptor transient receptor potenti ion channel famili cannabinoid known modul cutan inflamm pain itch rosacea high preval diseas associ signific degre morbid associ symptom transient receptor potenti ion channel known trigger rosacea may underli portion rosacea pathophysiolog articl aim detail transient receptor potenti channel pathway rosacea known effect cannabinoid pathway discuss potenti role cannabinoid treat rosacea | D002186;D012393 | T047;T121;T109 |
34,664,380 | open versus laparoscop later lymph node dissect mid low rectal cancer propens score match studi studi aim evalu periop patholog oncolog outcom open versus laparoscop total mesorect excis tme plus later lymph node dissect llnd mid low rectal cancer use propens score match | D010535;D012004 | T061;T191;T060 |
34,664,371 | gut microbiota gut diseas gut microbiota key role mainten good health pathogenesi gastrointestin diseas condit includ inflammatori bowel diseas colorect cancer coeliac diseas metabol liver diseas although natur microbi disturb condit fulli characteris prevent develop microbi base therapi microbi chang therapi may address newli recognis pathophysiolog contributor diseas potenti replac supplement standard therapi antibiot play role initi clostridiod difficil diseas specif inflammatori disord probiot limit proven role faecal microbiota transplant proven therapeut benefit recurr c difficil diseas ulcer coliti review current literatur microbiota target therapi gut disord | D016360;D000069196;D015212;D064307;D019936 | T007;T047;T001;T032;T028 |
34,664,370 | reflect pandem th anniversari univers new south wale medic school march univers new south wale enrol first student new faculti medicin rank th australia th world author fortun member pioneer group look back gratitud visionari commit academ mentor made happen mani foundat academ fellow royal australasian colleg physician two becom univers new south wale dean medicin one quarter foundat year graduat becam fellow colleg first phd medic graduat professor john chalmer ac becam presid colleg | D000846;D012577 | T052;T051;T093;T073 |
34,664,369 | anticoagul prescrib practic follow ischaem stroke set non valvular atrial fibril well establish anticoagul follow ischaem stroke set non valvular atrial fibril effect mean secondari prevent howev lack solid evid base guid agent choic optim time initi anticoagul therapi decis complex consider requir balanc risk recurr stroke potenti caus exacerb parenchym haemorrhag clinic audit perform high volum primari stroke centr look anticoagul prescrib practic among neurologist found apixaban far anticoagul choic non valvular atrial fibril median time anticoagul initi day post transient ischaem attack day post small infarct day post moder infarct day post larg infarct | D001281;D002545;D000083242;D020521 | T047;T046 |
34,664,368 | depress patient make decis request voluntari assist die depress symptom includ part major depress disord common end life number psychiatrist consid diagnosi major depress preclud capac make decis request voluntari assist die vad although unanim view paper use case patient two differ psychiatr opinion form regard capac make decis request vad differ view relat whether major depress diagnos associ made depress capac request vad view absenc major depress requir order establish capac request vad potenti odd legal definit necessarili keep patient experi end life | D003865;D017236 | T048;T054 |
34,664,367 | imag patient multipl myeloma associ plasma cell disord consensus practic statement medic scientif advisori group myeloma australia imag modal multipl myeloma mm evolv enabl earlier detect diseas furthermor diagnosi mm requir therapi recent chang includ diseas prior bone destruct specif detect focal bone lesion focal lesion earli abnorm area bone marrow may signal develop subsequ lytic lesion typic occur within next month cross section imag modal sensit detect monitor bone bone marrow diseas includ intern myeloma work group current consensus criteria initi diagnosi treatment respons assess aim consensus practic statement review evid support modal detail posit statement found myeloma australia websit | D009101;D010265 | T191;T047 |
34,664,365 | subcutan ertapenem deliv australian outpati parenter antimicrobi therapi servic retrospect compar efficaci studi subcutan sc administr ertapenem outpati parenter antimicrobi therapi opat servic may practic altern intraven deliveri complic infect clinic featur outcom accord rout administr compar larg australian opat servic chronic renal impair common sc group reflect opportun rout administr vein preserv strategi advers event uncommon success outcom differ group | D000890;D010045 | T121;T101 |
34,664,363 | predict cardiovascular event patient chronic myeloid leukaemia use baselin risk factor coronari arteri calcium score standardis method cardiovascular risk stratif chronic myeloid leukaemia patient treat tyrosin kinas inhibitor lack report algorithm risk stratif applic patient commenc tyrosin kinas inhibitor therapi base age prior cardiovascular diseas framingham risk score incorpor coronari arteri calcium score patient intermedi framingham risk score risk patient retrospect studi major advers cardiovascular event rate studi defin low intermedi high risk categori respect nine patient classifi intermedi low risk basi coronari arteri calcium score none went experi major advers cardiovascular event | D002318;D003324;D015464 | T191;T047 |
34,664,362 | ten year trend prescrib antiarrhythm drug australian primari care patient atrial fibril despit chang antiarrhythm drug aad choic patient atrial fibril af trend aad prescrib remain investig aim examin chang use nationwid australian general practic data year aad prescrib patient af decreas main due reduct use amiodaron sotalol digoxin contrast use beta blocker flecainid increas | D000638;D001281 | T047;T121;T109;T046 |
34,664,361 | qualit studi nuclear medicin physician percept positron emiss tomographycomput tomographi pregnant patient cancer stage use positron emiss tomographycomput tomographi petct standard care mani cancer occur frequent pregnanc particular lymphoma expert guidelin general recommend petct pregnant women emerg evid like absorb foetal dose pregnanc relat low certain circumst petct may accept balanc benefit risk conduct qualit survey nuclear medicin physician australia new zealand assess practic attitud respect petct pregnanc women find respond consid petct pregnanc may appropri modal care select clinic context appropri modif import continu defin role petct pregnanc futur particular imag modal emerg standard care stage respons assess mani cancer | D009369;D009683;D010820 | T091;T191;T097 |
34,664,359 | thought attitud toward disast among japanes patient type diabet qualit descript studi purpos studi clarifi thought attitud patient type diabet disast | D003922;D004189;D004190 | T052;T047;T067;T064 |
34,664,357 | efficaci combin fraction carbon dioxid laser topic tazaroten nail psoriasi treatment random intrapati left right studi treatment nail psoriasi disappoint due poor penetr topic therapi variabl efficaci system therapi fraction carbon dioxid laser fcl may enhanc penetr topic therapi nail psoriasi | D003879;D054020;D009260;D011565 | T047;T074;T121;T073 |
34,664,356 | cellulos synthas like protein oscsld play import role respons rice salt stress mediat abscis acid biosynthesi regul osmot stress toler cell wall polysaccharid biosynthesi enzym play import role plant growth develop stress respons function cell wall polysaccharid synthesi enzym plant growth develop well studi contrast role plant respons environment stress poor understood previous studi demonstr rice cell wall cellulos synthas like protein oscsld involv cell wall polysaccharid synthesi import rice growth develop studi demonstr oscsld function disrupt mutant nd sensit salt stress insensit abscis acid aba express aba synthesi respons gene repress nd normal salt stress condit exogen aba restor nd impair salt stress toler moreov overexpress oscsld enhanc rice aba synthesi gene express increas aba content improv rice salt toler thus impli oscsld regul rice salt stress toler mediat aba synthesi addit nd decreas rice toler osmot stress ion toxic toler result transcriptom analysi show osmot stress respons gene impair nd salt stress respons gene thus indic oscsld involv rice salt stress respons aba induc osmot respons pathway intrigu disrupt oscsld function decreas grain width weight overexpress oscsld increas grain width weight taken togeth studi demonstr novel plant salt stress adapt mechan crop coordin salt stress toler yield | D012275 | T002;T168 |
34,664,352 | role peer support hepat c elimin programm mani peopl chronic hepat c infect nt engag treatment elimin hepat c avoid health inequ therapi must provid everyon diseas peer live experi condit improv care hepat c studi shown unequivoc benefit complet retrospect analysi english nation health servic treatment registri compar treatment network without peer use bayesian poisson count outcom bayesian binomi proport outcom mix effect model time fix effect outcom estim relat ratio rr poisson model odd ratio odd ratio binomi model peer non peer network analys patient within oper deliveri network network peer increas number peopl initi therapi rr credibl interv increas proport complet therapi credibl interv howev saw chang proport peopl use drug initi therapi signific chang virolog respons credibl interv repeat analysi look impact peer two month introduc establish network contact saw increas proport peopl treat addict servic treat patient chronic hepat c infect inclus peer support may increas number peopl initi complet antivir therapi | D006526;D019698 | T047 |
34,664,350 | role pchhi abc transport iron acquisit siderophor pyochelin pseudomona aeruginosa iron essenti nutrient bacteri growth poor bioavail bacteria scaveng ferric iron synthes secret siderophor small compound high affin iron pyochelin pch one two siderophor produc opportunist pathogen pseudomona aeruginosa captur ferric iron molecul pch fe import back bacteria first outer membran transport fpta inner membran permeas fptx use molecular biolog fe uptak assay lc msms quantif first find role pchhi heterodimer abc transport involv siderophor free iron uptak bacteri cytoplasm also provid first evid pch abl reach bacteri periplasm cytoplasm fpta fptx express final detect interact pchh fptx link abc transport pchhi inner permeas fptx pch fe uptak pathway result pave way better understand pch siderophor pathway give futur direct tackl p aeruginosa infect | D011550;D017262 | T007;T109;T123 |
34,664,349 | novel loop neurorrhaphi techniqu preserv lower lip sensat mandibular reconstruct use innerv vascular iliac bone flap studi aim introduc novel loop neurorrhaphi techniqu use innerv vascular iliac bone flap vibf vascular ilioinguin nerv iin reconstruct inferior alveolar nerv ian preserv lower lip sensat simultan mandibular reconstruct | D063175;D019651 | T061 |
34,664,347 | intern popul studi spain cuba unit state attitud toward organ donat among cuban popul cuban immigr constitut import group unit state spain differ behavior toward organ donat describ among differ latin american nation analyz attitud toward organ donat among cuban popul cuba spain florida studi popul cuban immigr year age resid cuba spain florida sampl random stratifi age sex valid questionnair psychosoci aspect organ donat pcid dto rio use census use sampl base countri howev addit spain unit state florida sought support immigr support associ determin cuban popul without legal document questionnair complet anonym self administ complet rate studi among survey spain florida cuba attitud favor donat organ upon death survey spain florida cuba global sampl multivari analysi show countri resid independ factor associ attitud toward organ donat odd ratio factor associ attitud sex educ level perform prosoci activ knowledg brain death concept religion coupl opinion toward donat fear mutil donat attitud toward manipul bodi death attitud toward organ donat among cuban countri origin immigr spain similar signific differ emigr florida attitud much less favor | D054242;D016031;D016377;D009927 | T098;T055;T073;T061;T058;T033 |
34,664,346 | demystifi mentorship tip success navig mentor mente journey qualiti mentorship crucial long term success academia overal job satisfact unfortun formal mentorship train lack littl recours fail mentor mente relationship | D000071252;D008611 | T065;T098 |
34,664,345 | retrospect analysi investig practic acut limb ischaemia present unknown aetiolog acut limb ischaemia ali limb life threaten condit signific morbid current consensus recommend investig practic determin aetiolog ali present without known aetiolog undertook detail analysi investig perform identifi under precipit unexplain ali formul suggest diagnost algorithm evalu unexplain ali | D016491;D013927 | T047;T046 |
34,664,344 | decreas rate inpati pediatr bipolar disord diagnosi us diagnosi bipolar disord bd increas substanti among youth mid mid unit state dramat increas diagnosi result concern regard potenti misdiagnosi bd among youth howev rate bd diagnosi unit state evalu nation sinc mid unclear whether chang diagnost rate continu occur therefor present studi aim assess pattern longitudin trend rate nation inpati bd diagnosi subsequ | D001714 | T048 |
34,664,343 | effect spatio tempor variabl host fish speci farm biosecur measur preval potenti pathogen aeromona speci freshwat fish farm determin preval aeromona speci freshwat fish farm factor affect preval virul factor associ speci | D000333;D016905 | T007;T047 |
34,664,341 | prognosi sandwich mode postop chemotherapi radiat patient local advanc cervic cancer studi aim evalu surviv outcom differ postop radiat chemotherapi mode local advanc cervic cancer lacc | D002583 | T191 |
34,664,340 | self rate pittsburgh sleep qualiti index reflect actigraphi record sleep qualiti variabl exploratori studi bipolar disord versus healthi control sleep disturb typic symptom acut episod bipolar disord bd differenti euthym bd case healthi control hc research often employ object record evalu sleep pattern actigraphi whilst clinician often use subject rate pittsburgh sleep qualiti index psqi evid suggest measur may disagre decid compar subject psqi object week actigraphi sleep profil bd case hc n examin whether dimension approach help illustr differ pattern sleep disturb whether concord subject object record vari accord clinic status bd versus hc princip compon analysi pca extract two factor psqi separ pcas actigraphi record extract two factor mean valu sleep paramet one factor intra individu variabl correl linear regress analys pca deriv dimens demonstr bd hc psqi sleep durat effici factor signific correl actigraphi sleep initi durat factor furthermor bd case psqi total score psqi sleep impair factor signific correl actigraphi sleep variabl factor overal found subject experi sleep may modul differ compon object record sleep bd compar hc also use pca enabl us consid multi dimension natur subject sleep whilst inclus intra individu sleep variabl afford subtl evalu object sleep | D001714;D012893 | T048;T047 |
34,664,339 | assess readi implement patient navig program toronto canada explor factor influenc implement patient navig program within hospit senior complex care need | D062526 | T097;T058 |
34,664,338 | examin fetal well evalu metric fetal growth restrict seen japan obstetr compens caus analysi report data advanc perinat care improv prognos mother neonat howev cerebr palsi continu occur studi examin method intragest evalu health infant later develop cerebr palsi retrospect review conduct light date case among caus analysi report issu japan obstetr compens system januari septemb examin determin non stress test ultrason doppler test use evalu fetal well moreov observ case addit test perform even fetal growth restrict fgr identifi appropri manag fgr may help reduc incid cerebr palsi | D019985;D005317 | T046;T081 |
34,664,337 | retent cari prevent effect four differ sealant materi year prospect split mouth studi aim observ split mouth studi compar retent cari protect effect four differ sealant materi children age year year follow period | D003731;D010895 | T033;T047;T122 |
34,664,336 | novel walk clinic treatment intervent youth present anxieti depress articl explor novel singl session treatment intervent anxieti depress extern process transform metaphor imageri shift under maladapt emot schema within walk counsel set | D001008;D003863 | T048;T184 |
34,664,334 | biomimet dna nanotechnolog understand control cellular respons cellular level numer nanocu guid cell adher interact prolifer differenti etc understand manipul cellular function vitro necessit elucid nanocu provid cell extracellular matrix ecm neighbour cell form ligand dna nanotechnolog biocompat flexibl promis molecular level toolkit mimick cell cell cell matrix interact review summar various advanc cell matrix cell cell cell receptor ligand interact use dna nanotechnolog tool also provid brief outlook current challeng futur potenti dna base nanostructur inspir novel innov field | D032701;D049329 | T073;T090 |
34,664,333 | associ tactil intimaci sleep qualiti healthi adult systemat review prior research suggest differ type touch affect sleep whether consist associ tactil intimaci sleep qualiti unclear report pre regist systemat review intern prospect regist systemat review prospero crd studi examin associ tactil intimaci sleep qualiti healthi adult databas psycinfo pubm web scienc cochran central regist control trial embas search august total studi met inclus criteria synthesis qualit common articl research sexual intimaci relat sleep qualiti studi also investig non sexual affect touch emot neutral touch evid connect sexual function sexual satisfact masturb sleep qualiti found howev evid associ sexual frequenc sexual posit sleep found interest studi employ subject approach like report associ touch sleep potenti highlight discrep self report object measur associ touch sleep | D000089943;D014110 | T033;T042 |
34,664,331 | lncrna linc promot oral squamous cell carcinoma growth via enhanc upstream transcript factor mediat mitochondri ribosom protein l transcript linc long intergen non protein code rna identifi oncogen lncrna multipl cancer current studi aim explor transcript profil linc oral squamous cell carcinoma oscc regul transcript level | D002294;D006258;D035683;D009062 | T191;T114;T123 |
34,664,330 | review articl emerg issu pediatr skin color part dermatolog pediatr skin color popul applic dermatolog genet divers distinct segment pediatr popul includ children non white racial ethnic group increas pigment includ individu asian latinx african nativ american pacif island descent indigen peopl among other overlap particular individu mixtur thereof treat children color uniqu skill set within field pediatr dermatolog requir knowledg sensit disciplin pediatr skin color challeng difficulti diagnosi common condit stem under pigment variat common hairstyl practic differ demograph cutan diseas wherea condit common children color condit nuanc clinic appear andor therapeut regard skin color articl first seri two articl look recent publish skin relat issu high concern children color condit review part includ hairstyl hair relat concern traction alopecia central centrifug cicatrici alopecia endocrin disrupt autoimmun concern cutan lupus vitiligo infect tinea capiti progress macular hypomelanosi | D012871;D012880 | T047;T042 |
34,664,329 | effect low moder physic activ older adult chronic diseas systemat review meta analysi examin evid low moder intens physic activ assess effect manag hypertens diabet mellitus hyperlipidaemia condit among communiti dwell older adult | D002908;D015444 | T061;T047;T056 |
34,664,328 | protein data bank japan celebr th anniversari global pandem asian hub three dimension macromolecular structur data protein data bank japan pdbj found member worldwid protein data bank wwpdb accept process distribut experiment determin biolog macromolecular structur year time continu made major improv queri search interfac pdbj mine bmrbj web interfac em navig pdbbmrbemdb entri pdbj also serv pdb relat secondari databas data origin web base model servic homolog model complex structur homco visual servic util tool continu enhanc expand throughout year addit recent develop sever uniqu archiv bsm arc comput structur model xrda raw x ray diffract imag promot open scienc structur biolog communiti covid pandem pdbj also start provid featur page covid relat entri across avail archiv pdbj raw experiment data pdb structur data comput predict model also provid covid outreach content high school student teacher | D030562 | T170 |
34,664,327 | kidney transplant outcom elder recipi control donat circulatori death donat brain death donor registri cohort studi number kidney transplant kt procedur control donat circulatori death cdcd donor exponenti increas spain recent year parallel increas donor recipi accept criteria outcom cdcd kt report compar kt donat brain death dbd donor howev studi elder recipi yield contradictori result perform registri analysi kt recipi age year dbd kt group cdcd kt group catalonia spain clinic outcom surviv compar dbd kt cdcd kt recipi donor recipi age similar two group year donor year recipi delay graft function dgf frequent among cdcd kt recipi without differ rate primari nonfunct year patient death censor graft surviv rate similar dbd kt cdcd kt recipi vs vs respect multivari analysi previous cardiovascular diseas dgf independ risk factor patient death type donat cdcd vs dbd independ risk factor patient surviv graft loss cdcd kt dbd kt provid compar patient graft surviv elder recipi | D016030;D009927 | T073;T055;T061;T058;T033 |
34,664,326 | abil photocur gelatin prevent strictur recurr urethr dilat rabbit evalu abil photocur gelatin prevent strictur recurr urethr dilat rabbit urethr strictur model | D014521;D014525 | T190;T047;T023 |
34,664,325 | influenti factor adher physic activ exercis among communiti dwell stroke survivor path analysi investig status physic activ exercis pae adher identifi influenti factor among communiti dwell stroke survivor | D020521;D000071939 | T047;T061 |
34,664,323 | melanoma children adolesc analysi suscept gene italian patient polygen inherit involv high medium low penetr gene suggest melanoma suscept adult genet inform scarc paediatr patient | D008545;D012878 | T191 |
34,664,322 | relat diamet later screw pull strength distal clavicl fractur plate differ geometri cadaver biomechan studi plate fixat recent gain popular among various surgic method use treat neer type ii distal clavicl fractur use low profil distal clavicl lock plate logic consid better option signific differ fixat strength insert mm diamet screw therefor purpos biomechan studi investig differ fixat strength among vari size screw use treat distal clavicl fractur studi perform pair shoulder girdl fresh frozen cadav creat type iia fractur neer classif osteotomi perform perpendicular longitudin axi clavicl medial end point conoid ligament two custom made fixtur design attach upper lower side instron fabric evalu mean maximum pull strength fixat use mm diamet screw n wherea mean pull strength fixat mm diamet screw n statist signific differ two group distal fragment fixat distal clavicl lock plate use two mm diamet screw show compar biomechan pull strength time zero set fixat hook plate use two mm diamet screw therefor fixat distal fragment low profil plate mm screw may prefer altern option distal fragment fractur clavicl extrem small | D002968;D050723 | T023;T037 |
34,664,321 | associ apolipoprotein e gene polymorph nonalcohol fatti liver diseas southern china case control studi apolipoprotein e apo polymorph report associ nonalcohol fatti liver diseas nafld conclus studi inconsist differ region present studi aim investig role apo genotyp nafld southern china | D011110 | T045 |
34,664,319 | investig multipl popul highlight vegfa polymorph modul anterior cruciat ligament injuri polymorph vegfa kdr encod protein associ anterior cruciat ligament acl injuri risk leverag collect sampl sweden poland australia investig associ function polymorph vegfa kdr suscept acl injuri risk use case control genet associ approach polymorph vegfa kdr genotyp haplotyp infer control case clinic diagnos acl ruptur vegfa signific overrepresent rs cc genotyp p fals discoveri rate fdr p odd ratio confid interv ci combin acl group compar combin control group vegfa rs ca rs ga rs gc g haplotyp signific p ci underrepres combin acl group compar combin control group addit g g construct signific p ci underrepres combin acl group compar combin con group find support associ vegfa rs cc genotyp increas risk ii vegfa g haplotyp reduc risk align priori hypothesi collect identifi genet interv within vegfa implic acl risk modul highlight import vascular regul ligament biolog | D000070598;D042461 | T116;T037;T123 |
34,664,315 | characterist distribut children exposur assess metal household dust china big data pilot studi explor pollut characterist metal household dust china exposur children studi search peer review paper publish analyz elig paper screen per decid strategi evalu sampl weight concentr swc metal explor sourc metal present quantit descript spatial temporari characterist children exposur metal multi rout general live scenario result show concentr metal rang mgkg swc cd household dust rural area time urban area swc ni urban area time rural area result show four princip compon extract cumul contribut rate reach exposur dose metal children age year present highest ingest metal fe zn mn pose inevit health risk children high exposur countermeasur carri minim children exposur metal household dust urgent establish environment health standard household dust | D016902;D019216 | T080;T069;T196 |
34,664,313 | impact ibd medic risk pneumonia pneumonia relat hospitalis nationwid cohort studi ibd patient limit data incid pneumonia pneumonia relat hospitalis ibd popul associ ibd medic outcom | D015212;D011014 | T047;T050 |
34,664,312 | examin psychometr properti interperson need questionnair among colleg student india second highest popul world suicid relat death india high adult particular increas risk howev empir examin factor contribut suicid india assess reliabl valid self report measur assess construct rare | D007398;D059020 | T080;T033;T054;T055 |
34,664,308 | repurpos breweri contamin yeast product strain low alcohol beer ferment number fungal isol recent obtain survey microbiota multipl breweri breweri product sought explor whether breweri contamin could repurpos benefici use beer ferment particular focus low alcohol beer yeast strain first screen util differ carbon sourc abil ferment brewer wort format desir aroma compound number strain appear maltos negat produc desir aroma without obvious flavour select scale wort ferment select strain effici reduc wort aldehyd ferment thus elimin undesir wort like flavour produc divers volatil aroma profil two strain trigonopsi cantarellii candida soja togeth commerci saccharomycod ludwigii refer strain select l scale wort ferment base aroma profil similar commerci refer beer sensori analysi use project map strain perform compar commerci refer cantarellii strain particular produc low amount flavour signific higher amount desir monoterpen alcohol tran geraniol strain also sensit common food preserv antifung compound unabl grow c suggest relat easili control breweri appear low risk pathogen studi show natur breweri microbiota exploit sourc non convent yeast low alcohol beer product | D001515;D015003 | T004;T168 |
34,664,306 | atyp complic hypospadia repair combin dorsal later subcoron urethrocutan fistula urethrocutan fistula ucf one common complic hypospadia repair hr present unusu combin later dorsal subcoron cldsc ucf dorsal ucf report children yet year old patient admit complaint cldsc ucf follow hr long fistula tract urethr meatus dorsal fistula orific excis togeth urethroplasti patient well postop dorsal penil ucf unusu complic occur total excis fistula tract togeth urethroplasti could consid prevent complic | D017577;D007021;D014548 | T190;T047;T019 |
34,664,305 | dysregul mitochondri sirtuin gene associ human male infertil mitochondri sirtuin sirt sirt sirt post translat modifi regul energi product bodi homeostasi mitochondri activ via differ substrat respons environment stressor present studi aim assess express sirt sirt sirt semen infertil men express analysi perform use q rt pcr mitochondri sirtuin gene signific regul semen infertil men compar fertil men mitochondri sirtuin gene express level correl mitochondri hsp express hsp express posit correl sirt sirt sirt express semen fertil men negat correl observ hsp semen infertil men mitochondri sirtuin gene semen fertil men data suggest dysregul mitochondri sirtuin gene caus mitochondri dysfunct due stress appear associ human male infertil compromis function structur sperm integr | D007248;D024101;D037761 | T116;T047;T184;T123;T033;T126 |
34,664,304 | influenc combin lifestyl modif new formula supplement antioxid antioestrogen activ mild idiopath abnorm semen paramet pilot studi unhealthi lifestyl environment factor may influenc semen paramet via oxid stress function hypogonad xenobiot aim studi evalu influenc diet supplement contain glutathion herb antioxid antioestrogen activ combin lifestyl improv semen paramet data medic record men age median idiopath abnorm semen paramet retrospect analys inclus criteria compris sperm concentr mlnml disord sperm motil andor vital andor morpholog good general health present previous diseas treatment may influenc fertil normal testicular volum patient advis chang lifestyl take supplement three month basic semen analysi serum fsh lh testosteron level perform prescrib therapi three month treatment median serum concentr fsh signific increas lh testosteron mean semen paramet signific increas total sperm count seem lifestyl chang support consumpt herb antioxid antioestrogen activ may suitabl first line therapi patient mild idiopath abnorm semen paramet serum concentr reproduct hormon | D000975;D012661 | T044;T121;T123;T039;T031 |
34,664,303 | vaccin induc immun thrombosi thrombocytopenia syndrom follow adenovirus vector sever acut respiratori syndrom coronavirus vaccin novel hypothesi regard mechan implic futur vaccin develop hypothes thrombosi thrombocytopenia syndrom recent describ administr adenovirus vector vaccin sever acut respiratori syndrom coronavirus sar cov occur result uniqu properti adenovirus vector widespread biodistribut throughout bodi antigen deliv megakaryocyt cell act part primari immun system distribut antigen within progeni platelet also key compon immun system interact antigen induc preform antiplatelet factor pf antibodi bind pf heparan sulfat complex absenc exogen heparin site heparan sulfat concentr vascular glycocalyx optim complex format caus thrombosi thrombocytopenia observ clinic hypothesi testabl cell cultur anim model potenti vivo proven correct signific implic vaccin develop understand link coagul immun system | D000086382;D013921;D013927;D014612 | T116;T047;T121;T129;T046;T067 |
34,664,302 | quantit measur trapeziometacarp joint pressur use cadaver model later pinch trapeziectomi perform trapeziometacarp tmc arthriti decreas later pinch strength major sourc discomfort surgeri magnitud decreas unclear howev pressur chang tmc joint unknown investig relationship design cadaver studi measur tmc joint pressur use later pinch model quantit evalu effect trapeziectomi pressur measur cadaver forearm physiolog forc appli across thumb tmc joint load five tendon therebi simul later pinch use pressur sensor measur later pinch pressur tmc joint pressur averag rang kgcm rang kgcm respect signific correl measur found averag ratio rang trapeziectomi interposit tendon ball use flexor carpi radiali pressur measur repeat condit signific chang found averag rang kgcm later pinch pressur rang kgcm tmc joint pressur conclus tmc joint pressur could measur ratio relat later pinch pressur use cadaver model trapeziectomi later pinch strength decreas wherea tmc joint pressur increas | D052737;D010003;D051222 | T023;T047;T030 |
34,664,301 | diet gut microbiom fatti liver associ liver cancer non alcohol fatti liver diseas nafld major caus chronic liver diseas worldwid consequ sedentari lifestyl overnutrit nafld could progress non alcohol steatohepat nash may develop cirrhosi hepatocellular carcinoma hcc gut microbiom one central regul host metabol diet could chang human gut microbiom rapid reproduc modul sever metabol pathway diet gut microbiom dysbiosi associ nafld relat hcc nafld hcc dietari cholesterol fiber fat carbohydr could chang microbiom composit contribut develop nash nafld hcc henc identif element gut liver axi primarili damag nash nafld hcc offer new possibl therapeut intervent review role gut microbiom microbi metabolit develop progress nafld nafld hcc first discuss impact differ diet composit includ cholesterol fiber fat sugar gut microbiom lead predisposit nash nafld hcc also explor summar articl discuss potenti therapeut implic diet microbiom modul fatti liver liver cancer | D006528;D004032;D000069196;D008113;D065626 | T191;T007;T047;T001;T168 |
34,664,299 | commiss infant mental health servic unit kingdom studi stakehold view infant regulatori disturb common stabl time compromis infant outcom across rang development domain mani problem origin within parent infant relationship special parent infant relationship team provid support intervent explicit aim address relationship difficulti howev current around team across unit kingdom half camh accept referr children year age | D002662;D008605 | T058 |
34,664,298 | limit evid moder associ gastrointestin symptom prospect healthcar utilis qualiti life individu drive seek medic help remain complex behaviour process incorpor psycholog social symptom specif factor within irrit bowel syndrom ib gastrointestin symptom predict small portion high healthcar seek experienc | D043183;D011788 | T047;T078 |
34,664,297 | predict factor success testicular sperm extract non obstruct azoospermia histori bilater cryptorchid normal testosteron studi aim assess predict factor success sperm retriev non obstruct azoospermia histori bilater cryptorchid retrospect studi includ patient azoospermia micro dissect testicular sperm extract januari januari median rang age patient wive studi group year respect patient low testosteron level ngdl prescrib human chorion gonadotropin iu inject everi day month persist low testosteron even hormon stimul exclud sperm retriev patient whilst fail patient univari analysi median testicular volum signific larger success group versus fail group p serum fsh serum lh signific lower success group p serum testosteron signific higher success group compar fail group p age orchidopexi lower success group versus fail group p multivari analysi averag testicular volum serum testosteron level independ factor success sperm retriev | D053713;D003456 | T033;T047;T019 |
34,664,296 | cytokin profil dynam gingiv develop human investig relationship cytokin profil fast slow pattern gingiv inflamm develop | D003773;D005891 | T047 |
34,664,295 | correl cytolog histolog case canin granulomat coliti boxer dog year old castrat male mix breed dog present north carolina state veterinari teach hospit chronic diarrhea hematochezia weight loss cytolog perform rectal scrape reveal macrophag contain magenta light pink variabl blue granular inclus phagocytos materi concern infecti organ histopatholog consist granulomat coliti identifi intra histiocyt bacteri organ confirm fluoresc situ hybrid fish tissu cultur confirm escherichia coli base find diagnosi granulomat coliti made patient success treat oral enrofloxacin near complet remiss sign achiev within week report describ case granulomat coliti mix breed dog first publish descript cytolog featur uncommon diseas offer valuabl cytolog histolog correl case cytolog help identifi featur consist granulomat coliti priorit differenti diagnos diagnost plan | D003424;D004283 | T047 |
34,664,294 | microbiom dental peri implant subgingiv plaqu peri implant mucos therapi random clinic trial assess microbi effect mechan debrid conjunct mouthrins site peri implant mucos gingiv | D015921;D003773;D064307;D052016;D057873 | T047;T074;T046;T001;T032;T028 |
34,664,293 | periarticular histiocyt sarcoma heart metastasi cat year old intact femal domest short hair cat refer recommend adjuv medic treatment month left forelimb amput due periarticular histiocyt sarcoma hs present physic abnorm limit enlarg ipsilater superfici cervic axillari lymph node routin blood analysi abdomin ultrasound thorac radiolog unremark cat initi receiv lomustin without advers event four week later cat develop sever acut respiratori distress result thorac radiograph transthorac echocardiograph analysi suggest pulmonari heart metastasi due cat poor clinic condit prognosi owner elect euthanasia necropsi perform base gross patholog histopatholog immunohistochemistri hs nodal renal pulmonari heart right auricular right ventricular metastas diagnos case repres first descript hs heart metastasi cat provid insight clinic cours metastat behavior rare malign neoplasm clinician awar site metastasi consid hs list differenti diagnos secondari heart tumor cat | D002371;D006338;D054747 | T191;T047 |
34,664,291 | aggress script rehears adult offend relationship emot regul difficulti aggress behavior studi explor relationship self report emot regul difficulti frequenc aggress script rehears aggress behavior adult male inmat signific moder posit correl found frequenc aggress script rehears emot regul difficulti overal well follow dimens difficulti control impuls experienc negat emot confid effect emot regul strategi signific weak posit correl found frequenc aggress script rehears two emot regul difficulti dimens lack understand emot respons difficulti deal goal direct behavior experienc uncomfort emot signific correl found aggress behavior emot regul difficulti except weak posit correl aggress behavior difficulti control impuls experienc negat emot multivari analys use assess whether frequenc aggress script rehears moder effect emot regul difficulti aggress behaviour signific improv predict aggress result consider interact aggress script rehears difficulti emot clariti aggress script rehears awar emot experi even account influenc age attitud toward violenc conclus result suggest rehears aggress script may function regul emot particular amongst peopl inattent emot difficulti understand emot experi | D057237;D000080103 | T041;T098 |
34,664,289 | surfac prostat metaplasia transit cell metaplasia superfici cluster small basophil cell uterin cervix preval gender affirm hysterectomi comparison benign hysterectomi cisgend women gender affirm surgeri becom common import pathologist recogn potenti benign find avoid misinterpret cervic transit cell metaplasia superfici cluster small basophil cell describ context gender affirm testosteron therapi find may misdiagnos high grade squamous intraepitheli lesion endometri cell pap smear prostat metaplasia report surfac squamous epithelium vagina uterin cervix individu undergo gender affirm androgen therapi find often associ nkx posit basal keratinocyt aim studi assess morpholog immunohistochem featur uterin cervix gender affirm hysterectomi comparison benign hysterectomi cisgend women | D002294;D002583 | T191 |
34,664,288 | sesamol amelior hepat lipid accumul oxid stress steatosi hepg cell via ppar signal pathway non alcohol fatti liver diseas nafld chronic hepatopathi caus disord lipid metabol liver sesamol phenol compound deriv sesam oil shown inhibit obes hyperlipidemia atherosclerosi previous investig howev prevent effect sesamol hepat steatosi oxid stress nafld well studi work sesamol observ allevi lipid accumul oxid stress high oleic acid cholesterol induc hepg cell thus indic sesamol involv regul hepat lipid metabol oxid injuri mechan studi found activ peroxisom prolifer activ receptor ppar signal pathway sesamol intervent regul gene protein express relat fatti acid oxid cholesterol efflux catabol thus acceler lipid consumpt reduc intracellular lipid accumul process nafld data suggest sesamol effect amelior hepat steatosi sesamol rich sesamol oil may potenti agent find therapeut strategi treat nafld practic applic sesamol sesamol rich sesam oil receiv much attent due perform hepat lipid regul result studi indic sesamol treatment could amelior hepat steatosi inhibit lipid accumul oxid stress thus demonstr sesamol sesam oil use function food nutraceut applic futur addit present work provid knowledg effect sesamol nafld involv mechan suppli nutrit guidelin sesam oil consumpt | D065626;D047492 | T192;T116;T047 |
34,664,287 | antiprolif wnt inhibitor wogonin prevent eryptosi follow ionophor challeng hyperosmot shock oxid stress metabol depriv anemia common complic chemotherapi may aris due prematur suicid death red blood cell rbcs prevent rbc death thus lend promis strategi counteract anemia wogonin wgn dihydroxi methoxyflavon wnt inhibitor deriv scutellaria baicalensi plant potent cytotox antitumor potenti howev natur interact wgn human rbcs unknown rbcs healthi particip expos differ hemolyt eryptot stimuli hr c presenc absenc wgn calcium overload induc ionomycin hyperosmot shock excess sucros oxid stress phenethyl isothiocyan peitc metabol depriv exclus glucos hemolysi estim extracellular hemoglobin phosphatidylserin ps exposur annexin v fitc intracellular calcium fluoam oxid stress dichlorodihydrofluorescein diacet h dcfda wgn rescu cell hemolyt activ ionomycin reduc ps extern interf calcium influx ionomycin treatment metabol exhaust wgn also signific inhibit ps exposur upon hyperosmot shock effect independ calcium entri moreov wgn exhibit antihemolyt anti eryptot activ peitc without appreci reduct ros level altogeth wgn prevent peitc induc hemolysi suppress eryptosi due calcium accumul hyperosmot shock oxid stress metabol exhaust novel insight may open new avenu therapeut applic wgn condit anemia common encount notabl cancer practic applic herbal supplement sho saiko xiaochaihu tang common prescrib reliev symptom liver diseas flavonoid herbal constitu sho saiko demonstr consider anti inflammatori antioxid antimicrobi antitumor immunomodulatori properti work identifi wgn major flavonoid sho saiko novel inhibitor hemolysi eryptosi human erythrocyt sinc inordin erythrocyt death major obstacl therapeut drug develop find argu use wgn natur altern either primari adjuv drug wide assort patholog condit includ cancer | D000072817;D004364 | T043;T121 |
34,664,286 | global burden attribut risk factor acut lymphoblast leukemia countri territori estim base global burden diseas studi provid foundat guidelin polici maker effici alloc medic resourc context popul age growth latest spatial distribut tempor trend acut lymphoblast leukemia along attribut risk factor sex age map base global burden diseas studi estim annual percentag chang eapc calcul accord relat age standard rate calendar year quantifi tempor trend morbid mortal use appli spearman rank correl estim relationship eapc potenti influenc factor popul attribut fraction potenti risk factor relat disabl adjust life year estim compar risk assess framework result found new case increas signific worldwid age standard incid rate increas annual proport elder patient sharpli increas especi within higher socio demograph index sdi region smoke high bodi mass index remain predomin risk factor relat mortal notabl contribut high bodi mass index present increas trend conclus global burden steadili increas especi middl sdi region health measur new drug taken consider improv manag treatment elder due increas proport higher sdi region low sdi area attent paid environment problem caus industri develop | D012959 | T098;T078;T081;T080;T102 |
34,664,285 | cellular molecular mechan genistein prevent treatment diseas overview genistein simplest secondari metabolit soybean belong group compound call isoflavon phytoestrogen make soy isoflavon studi shown anti inflammatori anti apoptot anti angiogen effect genistein addit modulatori effect steroid hormon receptor review discuss pharmacolog therapeut effect genistein various diseas practic applic review discuss therapeut effect genistein main constitu soybean health condit antioxid anti inflammatori anti apoptot anti angiogen effect need attent pharmacolog properti genistein make natur isoflavon potenti treatment various diseas postmenopaus symptom cancer bone brain heart diseas special emphasi given result use clinic safe potent bioactiv molecul | D019833;D007529 | T121;T109;T123 |
34,664,283 | impact protein carbonyl chemic characterist hair surfac purpos studi clarifi impact protein carbonyl chemic characterist hair surfac focus hydrophob | D057927;D050050 | T044;T070;T080 |
34,664,282 | social occup outcom young peopl attend earli intervent mental health servic longitudin studi identifi trajectori social occup function young peopl two year present earli intervent mental health care identifi demograph clinic factor influenc trajectori | D012919 | T054 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.